New inhaler aims to shield hearts during stent procedures
NCT ID NCT07397351
Summary
This study tests whether an inhaled medicine called Aroxxen® can protect heart muscle during and after stent placement surgery. Researchers will enroll 180 patients with coronary artery disease who are having elective stent procedures. The trial aims to find the best dose and timing of the inhaled treatment to reduce heart damage markers while ensuring it's safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.